← Back to Search

Acupuncture for Pain Management in Lymphoma

Phase 3
Waitlist Available
Led By Gary Deng, MD, PhD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Pathological diagnosis of MM, HD or NHL
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 90 days
Awards & highlights

Study Summary

This trial will test whether adding acupuncture to usual pain management can reduce the amount of opioids needed to manage chemotherapy-induced pain, as well as study acupuncture's effects on other cancer treatment symptoms and quality of life.

Who is the study for?
This trial is for adults over 18 who are scheduled for high-dose chemotherapy and stem cell transplant within a month, diagnosed with Multiple Myeloma (MM), Hodgkin's Lymphoma (HD), or Non-Hodgkin's Lymphoma (NHL). They shouldn't be regular opioid users or have had acupuncture recently. People with very low white blood cells, platelets, or certain clotting issues can't join.Check my eligibility
What is being tested?
The study tests if acupuncture can reduce the need for opioids in managing chemotherapy-induced pain in myeloma and lymphoma patients. It compares usual pain management plus acupuncture to usual care alone, also looking at other symptoms and quality of life impacts.See study design
What are the potential side effects?
Acupuncture may cause minor side effects like bruising, bleeding at needle sites, dizziness, or fainting. Opioids can lead to addiction risk, constipation, nausea, drowsiness, confusion and respiratory depression.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with multiple myeloma, Hodgkin's disease, or non-Hodgkin's lymphoma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
symptom burden
the number of patients using opioids at a given time

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care plus AcupunctureExperimental Treatment3 Interventions
Acupuncture will start on Day 0 and continue once daily to Day 15, as long as the patient is inpatient or comes to the clinic for post-transplantation follow-up. to prevent severe pain. If acupuncture does not prevent severe pain, the participant will receive opioid medication as backup pain relief.
Group II: Usual CareActive Control2 Interventions
Will receive only the usual pain management approach, which includes opioid medication when needed for severe pain, according to the routine guidelines for their care.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,933 Previous Clinical Trials
585,322 Total Patients Enrolled
80 Trials studying Multiple Myeloma
85,867 Patients Enrolled for Multiple Myeloma
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,996,248 Total Patients Enrolled
Hackensack Meridian HealthOTHER
131 Previous Clinical Trials
27,944 Total Patients Enrolled
20 Trials studying Multiple Myeloma
1,120 Patients Enrolled for Multiple Myeloma

Media Library

Acupuncture Clinical Trial Eligibility Overview. Trial Name: NCT04459416 — Phase 3
Multiple Myeloma Research Study Groups: Usual Care, Usual Care plus Acupuncture
Multiple Myeloma Clinical Trial 2023: Acupuncture Highlights & Side Effects. Trial Name: NCT04459416 — Phase 3
Acupuncture 2023 Treatment Timeline for Medical Study. Trial Name: NCT04459416 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people will be involved in this experiment at most?

"That is correct, the online clinicaltrials.gov database has updated information that this study is still actively recruiting patients. The trial was first posted on 6/30/2020, and the most recent edit was on 9/27/2022. The study is looking for 300 participants from 3 different sites."

Answered by AI

What are the risks associated with traditional Chinese medical treatments such as Acupuncture?

"Acupuncture received a score of 3 because there is Phase 3 trial data supporting its efficacy and multiple rounds of data indicating that it is safe."

Answered by AI

Can new patients still enroll in this clinical trial?

"The clinical trial is currently recruiting at three sites for a total of 300 patients, according to the most recent update on clinicaltrials.gov (9/27/2022). This study was originally posted on 6/30/2020."

Answered by AI

Who else is applying?

What state do they live in?
Washington
How old are they?
18 - 65
What site did they apply to?
Seattle Cancel Care Alliance (Data Collection Only)
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
2020. "Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04459416.
All > Hodgkin Lymphoma
~66 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top